Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 12;12(9):1439.
doi: 10.3390/antibiotics12091439.

Polyclonal Multidrug ESBL-Producing Klebsiella pneumoniae and Emergence of Susceptible Hypervirulent Klebsiella pneumoniae ST23 Isolates in Mozambique

Affiliations

Polyclonal Multidrug ESBL-Producing Klebsiella pneumoniae and Emergence of Susceptible Hypervirulent Klebsiella pneumoniae ST23 Isolates in Mozambique

José João Sumbana et al. Antibiotics (Basel). .

Abstract

Globally, antibiotic-resistant Klebsiella spp. cause healthcare-associated infections with high mortality rates, and the rise of hypervirulent Klebsiella pneumoniae (hvKp) poses a significant threat to human health linked to community-acquired infections and increasing non-susceptibility. We investigated the phenotypic and genetic features of 36 Klebsiella isolates recovered from invasive infections at Hospital Central of Maputo in Mozambique during one year. The majority of the isolates displayed multidrug resistance (MDR) (29/36) to cephalosporins, gentamicin, ciprofloxacin, and trimethoprim-sulfamethoxazole but retained susceptibility to amikacin, carbapenems, and colistin. Most isolates were ESBLs-producing (28/36), predominantly carrying the blaCTX-M-15 and other beta-lactamase genes (blaSHV, blaTEM-1, and blaOXA-1). Among the 16 genomes sequenced, multiple resistance genes from different antibiotic classes were identified, with blaCTX-M-15, mostly in the ISEcp1-blaCTX-M-15-orf477 genetic environment, co-existing with blaTEM-1 and aac(3)-IIa in five isolates. Our results highlight the presence of polyclonal MDR ESBL-producing K. pneumoniae from eight sequence types (ST), mostly harbouring distinct yersiniabactin within the conjugative integrative element (ICE). Further, we identified susceptible hvKp ST23, O1-K1-type isolates carrying yersiniabactin (ybt1/ICEKp10), colibactin, salmochelin, aerobactin, and hypermucoid locus (rmpADC), associated with severe infections in humans. These findings are worrying and underline the importance of implementing surveillance strategies to avoid the risk of the emergence of the most threatening MDR hvKp.

Keywords: CTX-M-15; ESBL; K. pneumoniae; Mozambique; hypervirulent K. pneumoniae ST23; multidrug resistant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Antimicrobial resistance rates of K. pneumoniae isolated in Hospital Central of Maputo, Mozambique.

Similar articles

Cited by

References

    1. Chang D., Sharma L., Dela Cruz C.S., Zhang D. Clinical Epidemiology, Risk Factors, and Control Strategies of Klebsiella pneumoniae Infection. Front. Microbiol. 2021;12:750662. doi: 10.3389/fmicb.2021.750662. - DOI - PMC - PubMed
    1. Singh C.L., Cariappa M.P., Kaur M. Klebsiella oxytoca: An emerging pathogen? Med. J. Armed Forces India. 2016;72((Suppl. 1)):S59–S61. doi: 10.1016/j.mjafi.2016.05.002. - DOI - PMC - PubMed
    1. Karampatakis T., Tsergouli K., Behzadi P. Carbapenem-Resistant Klebsiella pneumoniae: Virulence Factors, Molecular Epidemiology and Latest Updates in Treatment Options. Antibiotics. 2023;12:234. doi: 10.3390/antibiotics12020234. - DOI - PMC - PubMed
    1. Diallo O.O., Baron S.A., Abat C., Colson P., Chaudet H., Rolain J. Antibiotic resistance surveillance systems: A review. J. Glob. Antimicrob. Resist. 2020;23:430–438. doi: 10.1016/j.jgar.2020.10.009. - DOI - PubMed
    1. Gonzalez-Ferrer S., Peñaloza H.F., Budnick J.A., Bain W.G., Nordstrom H.R., Lee J.S., Van Tyne D. Finding Order in the Chaos: Outstanding Questions in Klebsiella pneumoniae Pathogenesis. Infect. Immun. 2021;89:e00693-20. doi: 10.1128/iai.00693-20. - DOI - PMC - PubMed

LinkOut - more resources